Zum Inhalt springen
Home » Junshi Biosciences Announces 2024 Interim Financial Results and Provides Corporate Updates

Junshi Biosciences Announces 2024 Interim Financial Results and Provides Corporate Updates

Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences,” HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced its 2024 interim financial results and provided corporate updates.

Junshi Biosciences Announces 2024 Interim Financial Results and Provides Corporate Updates